Skip to content

Measuring the glycemic index of rice-based medical food for patients with diabetes mellitus as an alternative to imported products

Measuring the glycemic index of rice-based medical food for patients with diabetes mellitus as an alternative to imported products

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210731001
Enrollment
20
Registered
2021-07-31
Start date
2021-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers glycemic index postprandial glucose rice medical food

Interventions

Subjects are asked to drink 50g glucose solution (2 measurements on 2 separate days) within 12-15 minutes. Blood is drawn at baseline and 15,30,45,60,90,120 minutes to measure changes in plasma glucos
50g glucose solution (2 measurements),rice-based medical food (liquid), rice-based medical food (powder)

Sponsors

Agricultural Research Development Agency (ARDA)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age 18 years and older 2. fasting plasma glucose < 100mg/dL 3. no prior history of diabetes and no prior treatment with glucose-lowering drugs 4. no history of food allergy 5. participants taking aspirin, birth control pills, vitamins and supplements, anti-hypertensive drugs, osteoporosis drugs at stable doses for 1 month or more are eligible for study inclusion

Exclusion criteria

Exclusion criteria: 1. significant medical problems requiring ongoing treatment, including but not limited to cancer, cardiac, pulmonary, hepatic, brain diseases or severe infection within 1 year before study inclusion 2. surgery or hospital admission within 3 months before study inclusion 3. history of allergy to medical food (or one or more of its components) used in the current study 4. pregnancy and lactation 5. use of thyroid hormones 6. history of diabetes or previous use of glucose-lowering drugs or insulin 7. diagnosis of diseases which significantly affect food digestion and absorption such as inflammatory bowel disease, Crohn's disease, ulcerative colitis 8. treatment with medications which can affect blood glucose levels, such as steroids, protease inhibitors, and antipsychotic drugs

Design outcomes

Primary

MeasureTime frame
Glycemic index, postprandial glucose area under the curve (AUC) 0-120min glycemic index equals (glucose AUC from medical food) / (glucose AUC from 50g glucose )

Secondary

MeasureTime frame
Insulin response, insulin AUC 0-120min Insulin response equals (insulin AUC from medical food) / (insulin AUC from 50g glucose)

Countries

Thailand

Contacts

Public ContactPornpoj Pramyothin

Mahidol University

pornpoj.pra@mahidol.edu024199322

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026